Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aging | 21 | 2018 | 75 | 4.610 |
Why?
|
| Cognition | 22 | 2018 | 73 | 3.360 |
Why?
|
| Cognitive Dysfunction | 17 | 2018 | 53 | 3.360 |
Why?
|
| Cognition Disorders | 14 | 2017 | 60 | 2.880 |
Why?
|
| Dementia | 8 | 2018 | 31 | 2.230 |
Why?
|
| Aged | 46 | 2018 | 414 | 2.140 |
Why?
|
| Male | 51 | 2018 | 1036 | 2.090 |
Why?
|
| Female | 51 | 2018 | 966 | 2.080 |
Why?
|
| Brain | 13 | 2018 | 92 | 2.050 |
Why?
|
| Aged, 80 and over | 40 | 2018 | 209 | 1.920 |
Why?
|
| Alzheimer Disease | 18 | 2018 | 80 | 1.860 |
Why?
|
| Humans | 53 | 2018 | 1883 | 1.860 |
Why?
|
| Longitudinal Studies | 27 | 2018 | 80 | 1.680 |
Why?
|
| DNA-Binding Proteins | 6 | 2018 | 21 | 1.380 |
Why?
|
| Neuropsychological Tests | 19 | 2018 | 107 | 1.210 |
Why?
|
| Neurodegenerative Diseases | 3 | 2018 | 16 | 1.160 |
Why?
|
| Cognitive Aging | 4 | 2018 | 6 | 0.960 |
Why?
|
| Middle Aged | 12 | 2017 | 488 | 0.740 |
Why?
|
| Disease Progression | 5 | 2017 | 43 | 0.720 |
Why?
|
| Memory | 3 | 2016 | 20 | 0.710 |
Why?
|
| Depression | 3 | 2016 | 27 | 0.710 |
Why?
|
| Memory, Episodic | 2 | 2018 | 6 | 0.670 |
Why?
|
| Chicago | 9 | 2018 | 56 | 0.660 |
Why?
|
| Follow-Up Studies | 12 | 2017 | 69 | 0.630 |
Why?
|
| Health Literacy | 2 | 2017 | 6 | 0.630 |
Why?
|
| Hippocampus | 2 | 2016 | 19 | 0.610 |
Why?
|
| Memory Disorders | 2 | 2017 | 14 | 0.600 |
Why?
|
| Neurofibrillary Tangles | 3 | 2017 | 7 | 0.560 |
Why?
|
| Learning | 1 | 2018 | 14 | 0.560 |
Why?
|
| Ambulatory Care | 1 | 2017 | 3 | 0.540 |
Why?
|
| Chronic Disease | 1 | 2017 | 15 | 0.540 |
Why?
|
| Hospitalization | 1 | 2017 | 22 | 0.530 |
Why?
|
| Lewy Bodies | 2 | 2017 | 10 | 0.530 |
Why?
|
| Amyloid beta-Peptides | 2 | 2017 | 10 | 0.520 |
Why?
|
| Cohort Studies | 11 | 2018 | 107 | 0.510 |
Why?
|
| Agnosia | 1 | 2016 | 1 | 0.510 |
Why?
|
| Loneliness | 4 | 2018 | 7 | 0.510 |
Why?
|
| Reading | 1 | 2016 | 1 | 0.500 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 9 | 0.490 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2017 | 41 | 0.490 |
Why?
|
| Brain Chemistry | 1 | 2016 | 7 | 0.490 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 9 | 0.490 |
Why?
|
| Personality | 1 | 2015 | 3 | 0.460 |
Why?
|
| Interpersonal Relations | 1 | 2014 | 4 | 0.450 |
Why?
|
| Apolipoprotein E4 | 5 | 2018 | 23 | 0.450 |
Why?
|
| Risk Factors | 13 | 2018 | 140 | 0.400 |
Why?
|
| Membrane Transport Proteins | 3 | 2017 | 7 | 0.400 |
Why?
|
| Parkinsonian Disorders | 3 | 2017 | 8 | 0.380 |
Why?
|
| Motor Activity | 3 | 2015 | 19 | 0.350 |
Why?
|
| Decision Making | 2 | 2018 | 14 | 0.260 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2017 | 3 | 0.260 |
Why?
|
| Autopsy | 5 | 2018 | 12 | 0.260 |
Why?
|
| Smell | 2 | 2016 | 6 | 0.250 |
Why?
|
| Awareness | 2 | 2016 | 3 | 0.250 |
Why?
|
| Logistic Models | 5 | 2017 | 27 | 0.250 |
Why?
|
| Cerebral Amyloid Angiopathy | 2 | 2015 | 3 | 0.240 |
Why?
|
| Stroke | 2 | 2016 | 31 | 0.240 |
Why?
|
| Proportional Hazards Models | 4 | 2017 | 19 | 0.220 |
Why?
|
| Time Factors | 4 | 2017 | 143 | 0.220 |
Why?
|
| Risk | 4 | 2018 | 23 | 0.210 |
Why?
|
| Independent Living | 3 | 2018 | 11 | 0.200 |
Why?
|
| Incidence | 6 | 2018 | 45 | 0.190 |
Why?
|
| Educational Status | 3 | 2017 | 22 | 0.190 |
Why?
|
| Age Factors | 3 | 2016 | 51 | 0.180 |
Why?
|
| Prospective Studies | 6 | 2018 | 118 | 0.180 |
Why?
|
| Apolipoproteins E | 2 | 2017 | 12 | 0.170 |
Why?
|
| Neoplasms | 2 | 2018 | 13 | 0.160 |
Why?
|
| Neuropathology | 2 | 2017 | 3 | 0.160 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 19 | 0.160 |
Why?
|
| Genotype | 5 | 2017 | 37 | 0.160 |
Why?
|
| United States | 5 | 2018 | 155 | 0.150 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 63 | 0.150 |
Why?
|
| Sclerosis | 2 | 2016 | 4 | 0.150 |
Why?
|
| Plaque, Amyloid | 2 | 2017 | 5 | 0.150 |
Why?
|
| Geriatric Assessment | 5 | 2017 | 12 | 0.150 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2016 | 19 | 0.150 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 3 | 0.150 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 11 | 0.150 |
Why?
|
| Osteoporosis | 1 | 2018 | 15 | 0.150 |
Why?
|
| Cerebral Infarction | 2 | 2015 | 6 | 0.140 |
Why?
|
| Perception | 1 | 2018 | 7 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 7 | 0.140 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 4 | 0.140 |
Why?
|
| Gene Expression | 1 | 2018 | 27 | 0.140 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 22 | 0.140 |
Why?
|
| Urinary Incontinence | 1 | 2017 | 3 | 0.140 |
Why?
|
| Haplotypes | 1 | 2017 | 5 | 0.140 |
Why?
|
| Literacy | 1 | 2017 | 1 | 0.140 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 13 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 29 | 0.130 |
Why?
|
| Homozygote | 1 | 2017 | 1 | 0.130 |
Why?
|
| Apolipoprotein E3 | 1 | 2017 | 2 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2017 | 4 | 0.130 |
Why?
|
| Parkinson Disease | 1 | 2017 | 42 | 0.130 |
Why?
|
| Adult | 2 | 2015 | 549 | 0.130 |
Why?
|
| Diabetes Complications | 1 | 2016 | 4 | 0.130 |
Why?
|
| Mortality | 1 | 2016 | 5 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 17 | 0.130 |
Why?
|
| Linear Models | 4 | 2017 | 18 | 0.130 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 59 | 0.130 |
Why?
|
| Neuroticism | 1 | 2016 | 1 | 0.120 |
Why?
|
| Biostatistics | 1 | 2016 | 1 | 0.120 |
Why?
|
| Sex Factors | 1 | 2016 | 42 | 0.120 |
Why?
|
| Models, Statistical | 1 | 2016 | 20 | 0.120 |
Why?
|
| Brain Stem | 1 | 2016 | 2 | 0.120 |
Why?
|
| HIV Infections | 1 | 2017 | 72 | 0.120 |
Why?
|
| Olfaction Disorders | 1 | 2016 | 1 | 0.120 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 17 | 0.120 |
Why?
|
| Factor Analysis, Statistical | 1 | 2015 | 8 | 0.120 |
Why?
|
| Mobility Limitation | 1 | 2015 | 1 | 0.120 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 9 | 0.120 |
Why?
|
| Motor Disorders | 1 | 2015 | 1 | 0.120 |
Why?
|
| Reaction Time | 1 | 2015 | 23 | 0.120 |
Why?
|
| Empathy | 1 | 2014 | 1 | 0.110 |
Why?
|
| Life Change Events | 1 | 2014 | 4 | 0.110 |
Why?
|
| Mental Recall | 1 | 2014 | 9 | 0.110 |
Why?
|
| Quality of Life | 1 | 2015 | 26 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2014 | 11 | 0.110 |
Why?
|
| Comorbidity | 3 | 2018 | 27 | 0.110 |
Why?
|
| Mental Status Schedule | 3 | 2017 | 9 | 0.100 |
Why?
|
| Odds Ratio | 3 | 2017 | 14 | 0.100 |
Why?
|
| Prognosis | 2 | 2018 | 28 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2018 | 36 | 0.060 |
Why?
|
| Lewy Body Disease | 2 | 2018 | 4 | 0.060 |
Why?
|
| Genetic Association Studies | 2 | 2017 | 6 | 0.060 |
Why?
|
| Likelihood Functions | 2 | 2017 | 5 | 0.060 |
Why?
|
| Illinois | 2 | 2017 | 14 | 0.060 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 19 | 0.060 |
Why?
|
| Alleles | 2 | 2016 | 27 | 0.060 |
Why?
|
| Disability Evaluation | 2 | 2015 | 5 | 0.060 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 14 | 0.040 |
Why?
|
| Prevalence | 1 | 2018 | 26 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 13 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 36 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2018 | 37 | 0.040 |
Why?
|
| Biomarkers | 1 | 2018 | 51 | 0.040 |
Why?
|
| Dementia, Vascular | 1 | 2018 | 2 | 0.040 |
Why?
|
| Social Isolation | 1 | 2018 | 2 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 16 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2017 | 5 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2017 | 2 | 0.030 |
Why?
|
| Diagnosis | 1 | 2017 | 1 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2017 | 8 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 2 | 0.030 |
Why?
|
| Tuberous Sclerosis | 1 | 2017 | 2 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 18 | 0.030 |
Why?
|
| tau Proteins | 1 | 2017 | 8 | 0.030 |
Why?
|
| Arteriolosclerosis | 1 | 2016 | 1 | 0.030 |
Why?
|
| Brain Infarction | 1 | 2016 | 3 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 3 | 0.030 |
Why?
|
| Anisotropy | 1 | 2016 | 8 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2016 | 6 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 18 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2016 | 9 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 95 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 31 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 59 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2016 | 35 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 5 | 0.030 |
Why?
|
| Mental Health | 1 | 2016 | 5 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2015 | 2 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2015 | 7 | 0.030 |
Why?
|
| Self Report | 1 | 2015 | 12 | 0.030 |
Why?
|
| Heterozygote | 1 | 2015 | 22 | 0.030 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2015 | 1 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2015 | 4 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 25 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 11 | 0.030 |
Why?
|
| Markov Chains | 1 | 2015 | 3 | 0.030 |
Why?
|